Exploring Robotic-assisted Thoracic Surgery for Lung Cancer
ROSE
1 other identifier
observational
55
1 country
2
Brief Summary
Background Surgery for lung cancer can be performed using open (thoracotomy) or minimally invasive techniques (Video Assisted Thoracic Surgery (VATS)). Despite being associated with fewer postoperative complications (PPCs) VATS is difficult to perform and is only used by 20-44% of thoracic surgeons in the UK. Robotic-Assisted Thoracic Surgery (RATS) maybe a more attractive minimally invasive approach. To date, no studies have explored the impact of RATS on exercise capacity or physical activity and although 1 study has looked at Heath Related Quality of Life (HRQOL) post-RATS compared to an open technique indicators of surgical technique were not controlled for. Furthermore, investigators have little understanding of patients' experience of RATS. Aims
- 1.To examine the variability of change in exercise capacity and health-related quality of life (HRQOL) between those who receive thoracotomy V RATS.
- 2.To compare the difference in post-operative physical activity (step and activity count), across 7 days, in those who receive thoracotomy V RATS.
- 3.To explore the manner in which patients appraise their experience of undergoing RATS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2017
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 12, 2017
CompletedFirst Submitted
Initial submission to the registry
August 29, 2018
CompletedFirst Posted
Study publicly available on registry
September 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 18, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2019
CompletedApril 27, 2022
April 1, 2022
2.1 years
August 29, 2018
April 26, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in exercise capacity assessed using the Incremental Shuttle Walk Test (ISWT)
Distance walked in meters
Baseline to 4-6 weeks post-surgery (visit 2)
Secondary Outcomes (9)
Change in physical activity assessed using an Activity Monitor
Immediately post-surgery to 1-week post-discharge
Change in health related quality of life assessed using self-reported questionnaire
Baseline to 3-6 days post-surgery (visit 1)
Change in disease-specific health related quality of life assess using a self-reported questionnaire
Baseline to 3-6 days post-surgery (visit 1)
Change in Health related quality of life assessed using self-reported questionnaire
Baseline to 4-6 weeks post-surgery (visit 2)
Change in disease-specific health related quality of life assessed using self-reported questionnaire
Baseline to 4-6 weeks post-surgery (visit 2)
- +4 more secondary outcomes
Other Outcomes (3)
Length of hospital stay
3month follow up
Hospital readmissions
3month follow up
Post-operative pulmonary complications
3month follow up
Study Arms (2)
Thoracotomy
Individuals referred for a lung resection via thoracotomy with a primary or secondary diagnosis of lung cancer. Those with a tumor \>7cm will be excluded.
Robotic-assisted thoracic surgery
Individuals referred for a lung resection via robotic-assisted thoracic surgery with a primary or secondary diagnosis of lung cancer. Those with a tumor \>7cm will be excluded.
Interventions
Minimally invasive surgery
Eligibility Criteria
Individuals referred for a lung resection with a primary or secondary diagnosis of lung cancer will be eligible, although those with a tumor \>7cm will be excluded. Individuals referred for a lung resection via thoracotomy will be recruited from James Cook University Hospital and those referred for RATS will be recruited from James Cook University Hospital or the Barts Health.
You may qualify if:
- Individuals referred for a lung resection via thoracotomy or RATS with a primary or secondary diagnosis of lung cancer
You may not qualify if:
- Tumor \>7cm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Teesside Universitylead
- South Tees Hospitals NHS Foundation Trustcollaborator
- Barts & The London NHS Trustcollaborator
Study Sites (2)
Barts Health NHS Trust
London, United Kingdom
James Cook University Hospital
Middlesbrough, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samantha Harrison
Teesside University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Reader in research
Study Record Dates
First Submitted
August 29, 2018
First Posted
September 5, 2018
Study Start
October 12, 2017
Primary Completion
November 18, 2019
Study Completion
November 20, 2019
Last Updated
April 27, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share